GSK to buy US biotech firm IDRx for up to $1.15 billion
(Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which
(Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which
BERLIN (Reuters) – Commerzbank (ETR:CBKG)’s supervisory board chairman Jens Weidmann said there is little chance for an amicable merger with UniCredit after
By Wayne Cole SYDNEY (Reuters) – Global stocks slid broadly on Monday while the dollar hit more than two-year peaks in the wake
BERLIN (Reuters) – Lufthansa expects its planned stake in Italy’s ITA Airways to increase the German flagship carrier’s profits by hundreds of
BERLIN (Reuters) – German sports car maker Porsche AG reported a 28% tumble in 2024 China sales on Monday, as persistent weakness
By Jamie McGeever ORLANDO, Florida (Reuters) -Theory suggests that the divergence in value between U.S. stocks and bonds will eventually get so extreme
(Reuters) – Citigroup (NYSE:C) has appointed Jeff Wu as Head of Markets Sales for China, effective immediately, aiming to unify
Investing.com – Taiwan stocks were lower after the close on Monday, as losses in the , Oil, Gas & Electricity and Computers
By Sinead Cruise and Tommy Reggiori Wilkes LONDON (Reuters) – For years, pressure on European banks and asset managers to bulk up to
Investing.com– Taiwanese chipmaking stocks clocked strong revenues in the fourth quarter, with Citi analysts projecting continued sales growth as the sector benefited